ISSN 2308-9113
AboutContactsEditorial StaffEditorial CouncilArchiveFor AuthorsFor Reviewers

Research

The study of the metabolic profile of cannabimimetic MDMB-2201 in urine using gas chromatography with mass spectrometric detection

Journal «MEDICINA» ¹ 3, 2019, pp.104-120

Authors

Kataev S. S.
PhD, Head, Forensic Chemistry Department1

Dvorskaya O. N.
PhD, Assistant Professor, Chair for Toxicological Chemistry2

Gofenberg M. A.
Head, Chemical and Toxicological Laboratory34; Senior Lecturer5

Dunilin A. V.
Head, Chemical and Toxicological Laboratory6

1Perm Regional Bureau of Forensic-Medical Expertise, Perm, Russia
2Perm State Pharmaceutical Academy, Perm, Russia
3Yekaterinburg Regional Narcological Clinic, Yekaterinburg, Russia
4Sverdlovsk Regional Clinical Psychiatric Hospital, Yekaterinburg, Russia
5Ural State Medical University, Yekaterinburg, Russia.
6Kurgan Regional Narcoligical Clinic, Kurgan, Russia.

Corresponding Author

Dvorskaya Oksana, e-mail: dvoksnik@gmail.com

Funding

The study had no sponsorship.

Conflict of interest

The authors declare no conflict of interest.

Abstract

The first cases of identifying consumers of cannabimimetics MDMB-2201 during urine testing for narcotic substances in the Russian Federation were registered in March-April 2019 in the cities of Tyumen, Yekaterinburg, and Kurgan., 15 main metabolites and markers of the cannabimimetic MDMB-2201 were identified in the urine of consumers of smoking mixtures using solid-phase extraction and gas chromatography with mass spectrometric detection. Mass spectra of electronic ionization of the identified metabolites of MDMB-2201 were obtained, the results of calculations of several physicochemical characteristics and the degree of conjugation of metabolites to establish the facts of taking the cannabimimetic MDMB-2201 in the analysis of obtained biologic objects are presented.

Key words

MDMB-2201, cannabimimetics, metabolites, urine, solid-phase extraction (SPE), gas chromatography – mass spectrometry (GC-MS)

DOI

References

1. Kataev S.S., Dvorskaya O.N., Melent’ev A.B. Identifikatsiya markerov nekotorykh sinteticheskikh kannabinoidov v biologicheskikh ob’yektakh: informatsionnoye pis'mo. [Identification of markers of some synthetic cannabinoids in biological objects: Information letter]. Izhevsk. 2017: 34 p. (In Russ.)

2. Kataev S.S., Dvorskaya O.N. Identifikaciya metabolitov kannabimimetika PB-22F v moche [Identification of PB-22F cannabimimetics’ metabolites in urine]. Butlerovskie soobshcheniya [Butlerov Communications] 2014; 37 (2): 114-21. (In Russ.)

3. O vnesenii izmeneniy v nekotoryye akty Pravitel'stva Rossiyskoy Federatsii v svyazi s sovershenstvovaniyem kontrolya za oborotom narkoticheskikh sredstv: postanovleniye Pravitel'stva Ros. Federatsii ot 23.03.2015 ¹ 578 [On introducing changes to certain cuts of the Government of the Russian Federation due to the improvement of control over the circulation of narcotic drugs: Decree of the Government of Russian Federation from 23 Mar 2015 No 1097]. Available from: http:// www.consultant.ru/document/cons­_doc­_LAW­_164873/ (In Russ.)

4. Banister S.D., Longworth M., Kevin R., Sachdev S., Santiago M., Stuart J., Mack J.B., Glass M., McGregor I.S., Connor M., Kassiou M. Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues. ACS Chem. Neurosci. 2016;7(9):1241-54. doi: 10.1021/acschemneuro.6b00137

5. Hasegawa K., Wurita A., Minakata K., Gonmori K., Yamagishi I., Nozawa H., Watanabe K., Suzuki O. Identification and quantification of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products. Forensic Toxicol. 2015; 33 (1): 112-21.

6. Kaneko S. Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014. Forensic Toxicol. 2017; 35 (2): 244-51.

7. Mogler L., Franz F., Rentsch D., Angerer V., Weinfurtner G., Longworth M., Banister S.D, Kassiou M., Moosmann B., Auwärter V. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples. Drug Test Anal. 2018; 10 (1): 196-205. doi: 10.1002/dta.2201.

8. Risseeuw M.D.P, Blanckaert P., Coopman V., Van Quekelberghe S., Van Calenbergh S., Cordonnier J. Identification of a new tert-leucinate class synthetic cannabinoid in powder and «spice-like» herbal incenses: Methyl 2-1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA). Forensic Sci Int. 2017; 273: 45-52. doi: 10.1016/j.forsciint.2017.01.023.